Tag:

Risperdal

Latest Headlines

Latest Headlines

Pennsylvania still trying get a slice of J&J Risperdal payouts

PA alleges that J&J oversold the drug's benefits while underselling the risks.

Docs go off-label more than 10% of the time

Writing prescriptions for off-label uses is a known and accepted practice. But more than 10% of the time?

Justice, J&J duel over Gorsky's contribution to kickback case

Alex Gorsky's name has surfaced in the U.S. government's Risperdal marketing lawsuit just weeks before he is supposed to step up into the role of CEO at Johnson & Johnson.

J&J's $1.2B Risperdal fine 'ups the ante' for other cases

Johnson & Johnson's new Risperdal fine isn't just a whopping big penalty. It's a big stone tossed into the company's legal problems.

UPDATED: Judge hits J&J with $1.1B penalty in Risperdal case

Like other juries before it, an Arkansas panel found that the company's Janssen unit soft-pedaled the antipsychotic drug's risks.

Arkansas jury hears state's claims against J&J

The state claims the company misled doctors about Risperdal and is seeking $1.25 billion in penalties.

J&J's Risperdal cases head to court in Texas, Arkansas

As Johnson & Johnson and the state of Arkansas start airing their arguments over Risperdal marketing, the company is going back to court in Texas, where it agreed to pay $158 million to settle a...

J&J's Weldon to get $143M in retirement

William C. Weldon, who oversaw Johnson & Johnson ( $JNJ ) during some of its most troubled years, will receive $143.5 million in retirement and deferred compensation after he relinquishes the CEO position, Bloomberg reports.

Feds reportedly demand $1.8B in Risperdal marketing probe

The Justice Department is far from satisfied with Johnson & Johnson's tentative Risperdal settlement of $1 billion. Not swayed by a J&J offer to boost the settlement to $1.3 billion, the feds want $1.8 billion instead.

U.S. wants more than $1B from J&J in Risperdal settlement

Johnson & Johnson ( $JNJ ) may have thought it had its Risperdal marketing problems almost wrapped up. But it was wrong. As The Wall Street Journal reports, Justice Department higher-ups have...